| human | Q5 |
| P496 | ORCID iD | 0000-0003-2970-4821 |
| P69 | educated at | Institut Gustave Roussy | Q266227 |
| P108 | employer | Institut Gustave Roussy | Q266227 |
| hôpital Foch | Q3145155 | ||
| P735 | given name | Mathieu | Q17484081 |
| Mathieu | Q17484081 | ||
| P106 | occupation | researcher | Q1650915 |
| Q112694918 | BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer |
| Q113757610 | Escherichia coli-specific CXCL13-producing TFH are associated with clinical efficacy of neoadjuvant PD-1 blockade against muscle-invasive bladder cancer |
| Q82278708 | Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging |
| Q63383798 | PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer |
| Q101212513 | PD-L1 testing in urothelial bladder cancer: essentials of clinical practice |
| Q51051743 | Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy. |
| Q125872460 | Probiotic-guided CAR-T cells for solid tumor targeting |
| Q91092634 | Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer |
Search more.